Cargando…

Development of Therapeutic Agent for Osteoarthritis via Inhibition of KIAA1199 Activity: Effect of Ipriflavone In Vivo

This study aimed to clarify the effects of ipriflavone, which effectively reduces KIAA1199 activity, on osteoarthritis (OA) development and progression in an in vivo OA mouse model. The OA model mice were divided into the ipriflavone (200 mg/kg/day) group and the control group. OA onset and progress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jiarui, Nishida, Yoshihiro, Koike, Hiroshi, Zhuo, Lisheng, Ito, Kan, Ikuta, Kunihiro, Sakai, Tomohisa, Imagama, Shiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419624/ https://www.ncbi.nlm.nih.gov/pubmed/37569797 http://dx.doi.org/10.3390/ijms241512422

Ejemplares similares

Overexpression of KIAA1199, a novel strong hyaluronidase, is a poor prognostic factor in patients with osteosarcoma
por: Ito, Kan, et al.
Publicado: (2021)

Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase
por: Koike, Hiroshi, et al.
Publicado: (2022)

Successful treatment with denosumab for pelvic fibrous dysplasia: A case report and review of the literature
por: Ikuta, Kunihiro, et al.
Publicado: (2021)

Surgical Treatment and Complications of Deep-Seated Nodular Plexiform Neurofibromas Associated with Neurofibromatosis Type 1
por: Ikuta, Kunihiro, et al.
Publicado: (2022)

Clinical results of active surveillance for extra‐abdominal desmoid‐type fibromatosis
por: Sakai, Tomohisa, et al.
Publicado: (2022)

Limitations and benefits of FDG‐PET/CT in NF1 patients with nerve sheath tumors: A cross‐sectional/longitudinal study
por: Nishida, Yoshihiro, et al.
Publicado: (2021)

Less-invasive fascia-preserving surgery for abdominal wall desmoid
por: Nishida, Yoshihiro, et al.
Publicado: (2021)

Spontaneous Regression of Brown Tumor in a Patient Treated With Peritoneal Dialysis
por: Ito, Kan, et al.
Publicado: (2021)

Cardiac metastases from primary myxoid liposarcoma of the thigh: a case report
por: Ikuta, Kunihiro, et al.
Publicado: (2020)

CEMIP (KIAA1199) regulates inflammation, hyperplasia and fibrosis in osteoarthritis synovial membrane
por: Deroyer, Céline, et al.
Publicado: (2022)

KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer
por: Kohi, Shiro, et al.
Publicado: (2017)

Efficacy of auranofin as an inhibitor of desmoid progression
por: Ito, Kan, et al.
Publicado: (2022)

Identification of KIAA1199 as a Biomarker for Pancreatic Intraepithelial Neoplasia
por: Suh, Han Na, et al.
Publicado: (2016)

Knockdown of KIAA1199 attenuates growth and metastasis of hepatocellular carcinoma
por: Liu, Jingmei, et al.
Publicado: (2018)

Hypoxia increases KIAA1199/CEMIP expression and enhances cell migration in pancreatic cancer
por: Oba, Takuya, et al.
Publicado: (2021)

Murine homologue of the human KIAA1199 is implicated in hyaluronan binding and depolymerization()
por: Yoshida, Hiroyuki, et al.
Publicado: (2013)

KIAA1199 expression and hyaluronan degradation colocalize in multiple sclerosis lesions
por: Marella, Mathieu, et al.
Publicado: (2018)

Transcriptional and Epigenetic Regulation of KIAA1199 Gene Expression in Human Breast Cancer
por: Kuscu, Cem, et al.
Publicado: (2012)

KIAA1199 as a potential diagnostic biomarker of rheumatoid arthritis related to angiogenesis
por: Yang, Xinyu, et al.
Publicado: (2015)

CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes
por: Deroyer, Céline, et al.
Publicado: (2019)

Overexpression of KIAA1199 is an independent prognostic marker in laryngeal squamous cell carcinoma
por: Huang, Meixiang, et al.
Publicado: (2020)

Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma
por: Zhai, Xiangyu, et al.
Publicado: (2020)

Ipriflavone and Ipriflavone loaded albumin nanoparticles reverse lipopolysaccharide induced neuroinflammation in rats
por: Yassa, Nashwa W., et al.
Publicado: (2020)

Retraction: Ipriflavone and Ipriflavone loaded albumin nanoparticles reverse lipopolysaccharide induced neuroinflammation in rats
Publicado: (2023)

Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells
por: Birkenkamp-Demtroder, K, et al.
Publicado: (2011)

Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival
por: Fink, Stephen P., et al.
Publicado: (2015)

NF-κB-induced KIAA1199 promotes survival through EGFR signalling
por: Shostak, Kateryna, et al.
Publicado: (2014)

Distinct Expression Pattern of a Deafness Gene, KIAA1199, in a Primate Cochlea
por: Hosoya, Makoto, et al.
Publicado: (2016)

KIAA1199 is a secreted molecule that enhances osteoblastic stem cell migration and recruitment
por: Chen, Li, et al.
Publicado: (2019)

Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial
por: Nishida, Yoshihiro, et al.
Publicado: (2020)

KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survival
por: Terashima, Masato, et al.
Publicado: (2014)

Early Insights into the Function of KIAA1199, a Markedly Overexpressed Protein in Human Colorectal Tumors
por: Tiwari, Amit, et al.
Publicado: (2013)

Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness
por: Jami, Mohammad-Saeid, et al.
Publicado: (2014)

Crohn’s Disease Fibroblasts Overproduce the Novel Protein KIAA1199 to Create Proinflammatory Hyaluronan Fragments
por: Soroosh, Artin, et al.
Publicado: (2016)

Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancer
por: Wang, Anqi, et al.
Publicado: (2020)

KIAA1199 deficiency enhances skeletal stem cell differentiation to osteoblasts and promotes bone regeneration
por: Chen, Li, et al.
Publicado: (2023)

Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis
por: Sakai, Tomohisa, et al.
Publicado: (2017)

KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker
por: Shen, Xiaoju, et al.
Publicado: (2022)

Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
por: Liu, Jingmei, et al.
Publicado: (2023)

KIAA1199 overexpression is associated with abnormal expression of EMT markers and is a novel independent prognostic biomarker for hepatocellular carcinoma
por: Jiang, Zhengchen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lvjs9akjk7h9947jbmej1ba8n9